378 related articles for article (PubMed ID: 23082878)
21. Analysis of expression and prognostic significance of vimentin and the response to temozolomide in glioma patients.
Lin L; Wang G; Ming J; Meng X; Han B; Sun B; Cai J; Jiang C
Tumour Biol; 2016 Nov; 37(11):15333-15339. PubMed ID: 27704357
[TBL] [Abstract][Full Text] [Related]
22. Pseudogenes of annexin A2, novel prognosis biomarkers for diffuse gliomas.
Li S; Zou H; Shao YY; Mei Y; Cheng Y; Hu DL; Tan ZR; Zhou HH
Oncotarget; 2017 Dec; 8(63):106962-106975. PubMed ID: 29291003
[TBL] [Abstract][Full Text] [Related]
23. Decreased FOXD3 Expression Is Associated with Poor Prognosis in Patients with High-Grade Gliomas.
Du W; Pang C; Wang D; Zhang Q; Xue Y; Jiao H; Zhan L; Ma Q; Wei X
PLoS One; 2015; 10(5):e0127976. PubMed ID: 26011451
[TBL] [Abstract][Full Text] [Related]
24. MicroRNA-210 overexpression predicts poorer prognosis in glioma patients.
Lai NS; Dong QS; Ding H; Miao ZL; Lin YC
J Clin Neurosci; 2014 May; 21(5):755-60. PubMed ID: 24382515
[TBL] [Abstract][Full Text] [Related]
25. Nrf2 Expressions Correlate with WHO Grades in Gliomas and Meningiomas.
Tsai WC; Hueng DY; Lin CR; Yang TC; Gao HW
Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27187376
[TBL] [Abstract][Full Text] [Related]
26. Overexpression of CD44 is associated with a poor prognosis in grade II/III gliomas.
Hou C; Ishi Y; Motegi H; Okamoto M; Ou Y; Chen J; Yamaguchi S
J Neurooncol; 2019 Nov; 145(2):201-210. PubMed ID: 31506754
[TBL] [Abstract][Full Text] [Related]
27. High bone sialoprotein (BSP) expression correlates with increased tumor grade and predicts a poorer prognosis of high-grade glioma patients.
Xu T; Qin R; Zhou J; Yan Y; Lu Y; Zhang X; Fu D; Lv Z; Li W; Xia C; Hu G; Ding X; Chen J
PLoS One; 2012; 7(10):e48415. PubMed ID: 23119009
[TBL] [Abstract][Full Text] [Related]
28. ALDH1A3: A Marker of Mesenchymal Phenotype in Gliomas Associated with Cell Invasion.
Zhang W; Liu Y; Hu H; Huang H; Bao Z; Yang P; Wang Y; You G; Yan W; Jiang T; Wang J; Zhang W
PLoS One; 2015; 10(11):e0142856. PubMed ID: 26575197
[TBL] [Abstract][Full Text] [Related]
29. Glioma-associated stem cells: a novel class of tumor-supporting cells able to predict prognosis of human low-grade gliomas.
Bourkoula E; Mangoni D; Ius T; Pucer A; Isola M; Musiello D; Marzinotto S; Toffoletto B; Sorrentino M; Palma A; Caponnetto F; Gregoraci G; Vindigni M; Pizzolitto S; Falconieri G; De Maglio G; Pecile V; Ruaro ME; Gri G; Parisse P; Casalis L; Scoles G; Skrap M; Beltrami CA; Beltrami AP; Cesselli D
Stem Cells; 2014 May; 32(5):1239-53. PubMed ID: 24375787
[TBL] [Abstract][Full Text] [Related]
30. The correlation of bone morphogenetic protein 2 with poor prognosis in glioma patients.
Yang X; Li D; Cheng S; Fan K; Sheng L; Zhang J; Feng B; Xu Z
Tumour Biol; 2014 Nov; 35(11):11091-5. PubMed ID: 25099618
[TBL] [Abstract][Full Text] [Related]
31. Identification of P4HA1 as a prognostic biomarker for high-grade gliomas.
Hu WM; Zhang J; Sun SX; Xi SY; Chen ZJ; Jiang XB; Lin FH; Chen ZH; Chen YS; Wang J; Yang QY; Guo CC; Mou YG; Chen ZP; Zeng J; Sai K
Pathol Res Pract; 2017 Nov; 213(11):1365-1369. PubMed ID: 28964577
[TBL] [Abstract][Full Text] [Related]
32. Histone H1.0--a potential molecular marker with prognostic value for patients with malignant gliomas.
Gabrovsky N; Georgieva M; Laleva M; Uzunov K; Miloshev G
Acta Neurochir (Wien); 2013 Aug; 155(8):1437-42. PubMed ID: 23812966
[TBL] [Abstract][Full Text] [Related]
33. P4HB and PDIA3 are associated with tumor progression and therapeutic outcome of diffuse gliomas.
Zou H; Wen C; Peng Z; Shao YΥ; Hu L; Li S; Li C; Zhou HH
Oncol Rep; 2018 Feb; 39(2):501-510. PubMed ID: 29207176
[TBL] [Abstract][Full Text] [Related]
34. Long non-coding RNA MEG3 regulates proliferation, apoptosis, and autophagy and is associated with prognosis in glioma.
Zhao H; Wang X; Feng X; Li X; Pan L; Liu J; Wang F; Yuan Z; Yang L; Yu J; Su R; Zhang Y; Ma L
J Neurooncol; 2018 Nov; 140(2):281-288. PubMed ID: 30284203
[TBL] [Abstract][Full Text] [Related]
35. Proteomics identification of PGAM1 as a potential therapeutic target for urothelial bladder cancer.
Peng XC; Gong FM; Chen Y; Qiu M; Cheng K; Tang J; Ge J; Chen N; Zeng H; Liu JY
J Proteomics; 2016 Jan; 132():85-92. PubMed ID: 26655504
[TBL] [Abstract][Full Text] [Related]
36. Collaborative overexpression of matrix metalloproteinase-1 and vascular endothelial growth factor-C predicts adverse prognosis in patients with gliomas.
Xu Y; Zhong Z; Yuan J; Zhang Z; Wei Q; Song W; Chen H
Cancer Epidemiol; 2013 Oct; 37(5):697-702. PubMed ID: 23870768
[TBL] [Abstract][Full Text] [Related]
37. Clinical and prognostic role of annexin A2 in adamantinomatous craniopharyngioma.
Wang Y; Deng J; Guo G; Tong A; Peng X; Chen H; Xu J; Liu Y; You C; Zhou L
J Neurooncol; 2017 Jan; 131(1):21-29. PubMed ID: 27640198
[TBL] [Abstract][Full Text] [Related]
38. Co-expression of midkine and pleiotrophin predicts poor survival in human glioma.
Ma J; Lang B; Wang X; Wang L; Dong Y; Hu H
J Clin Neurosci; 2014 Nov; 21(11):1885-90. PubMed ID: 25001988
[TBL] [Abstract][Full Text] [Related]
39. A four-protein expression prognostic signature predicts clinical outcome of lower-grade glioma.
Patil V; Mahalingam K
Gene; 2018 Dec; 679():57-64. PubMed ID: 30077762
[TBL] [Abstract][Full Text] [Related]
40. Expression and clinical significance of annexin A2 and human epididymis protein 4 in endometrial carcinoma.
Deng L; Gao Y; Li X; Cai M; Wang H; Zhuang H; Tan M; Liu S; Hao Y; Lin B
J Exp Clin Cancer Res; 2015 Sep; 34(1):96. PubMed ID: 26362938
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
